$255 Million is the total value of ARMISTICE CAPITAL, LLC's 34 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 81.8% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Buy | SPDR S&P 500 ETF TRput | $57,546,000 | +41.1% | 280,000 | +40.0% | 22.59% | +55.2% | |
ATRS | Buy | ANTARES PHARMA INC | $13,405,000 | -16.3% | 15,405,703 | +16.4% | 5.26% | -7.9% |
VNDA | Sell | VANDA PHARMACEUTICALS INC | $13,376,000 | -11.9% | 1,600,000 | -1.8% | 5.25% | -3.0% |
XNPT | Buy | XENOPORT INC | $12,835,000 | +116.5% | 2,846,000 | +163.5% | 5.04% | +138.1% |
RXDX | Buy | IGNYTA INC | $11,428,000 | -10.4% | 1,688,000 | +77.3% | 4.49% | -1.4% |
FRPT | Sell | FRESHPET INC | $10,057,000 | -30.1% | 1,372,000 | -19.0% | 3.95% | -23.1% |
BCOR | Buy | BLUCORA INC | $9,845,000 | +20.5% | 1,908,000 | +128.8% | 3.86% | +32.5% |
ACOR | Buy | ACORDA THERAPEUTICS INC | $9,469,000 | +0.6% | 358,000 | +62.7% | 3.72% | +10.7% |
HAIN | HAIN CELESTIAL GROUP INC | $9,164,000 | +1.3% | 224,000 | 0.0% | 3.60% | +11.4% | |
BDSI | Buy | BIODELIVERY SCIENCES | $8,760,000 | -30.2% | 2,712,000 | +3.5% | 3.44% | -23.2% |
HWAY | Buy | HEALTHWAYS INC | $8,476,000 | -8.5% | 840,000 | +16.7% | 3.33% | +0.6% |
TBPH | New | THERAVANCE BIOPHARMA INC | $7,520,000 | – | 400,000 | +100.0% | 2.95% | – |
TLRDQ | New | TAILORED BRANDS INC | $7,160,000 | – | 400,000 | +100.0% | 2.81% | – |
LVS | New | LAS VEGAS SANDS CORP | $6,408,000 | – | 124,000 | +100.0% | 2.52% | – |
SGYPQ | New | SYNERGY PHARMACEUTICALS DEL | $6,072,000 | – | 2,200,000 | +100.0% | 2.38% | – |
ARRY | New | ARRAY BIOPHARMA INC | $5,900,000 | – | 2,000,000 | +100.0% | 2.32% | – |
KATE | Sell | KATE SPADE & CO | $5,716,000 | -5.4% | 224,000 | -34.1% | 2.24% | +4.1% |
AEGR | Buy | AEGERION PHARMACEUTICALS INC | $5,543,000 | -54.3% | 1,498,000 | +24.6% | 2.18% | -49.8% |
DMD | Sell | DEMAND MEDIA INC | $5,480,000 | -13.8% | 1,096,000 | -5.2% | 2.15% | -5.2% |
NOMD | New | NOMAD HLDGS LTD | $5,118,000 | – | 568,000 | +100.0% | 2.01% | – |
BWLD | New | BUFFALO WILD WINGS INC | $4,740,000 | – | 32,000 | +100.0% | 1.86% | – |
TTWO | New | TAKE-TWO INTERACTIVE SOFTWAR | $4,671,000 | – | 124,000 | +100.0% | 1.83% | – |
PLAY | New | DAVE & BUSTERS ENTMT INC | $3,800,000 | – | 98,000 | +100.0% | 1.49% | – |
DECK | Sell | DECKERS OUTDOOR CORP | $3,595,000 | -53.6% | 60,000 | -63.4% | 1.41% | -48.9% |
CHEF | New | CHEFS WHSE INC | $3,571,000 | – | 176,000 | +100.0% | 1.40% | – |
SPNC | Sell | SPECTRANETICS CORP | $2,497,000 | -71.7% | 172,000 | -70.6% | 0.98% | -68.9% |
Buy | PERNIX THERAPEUTICS HLDGS INdebt 4.250% 4/0 | $2,484,000 | +383.3% | 6,300,000 | +215.0% | 0.98% | +432.8% | |
TENX | Buy | TENAX THERAPEUTICS INC | $2,399,000 | -26.1% | 1,170,000 | +18.2% | 0.94% | -18.7% |
EXPR | New | EXPRESS INC | $2,312,000 | – | 108,000 | +100.0% | 0.91% | – |
RLOC | Buy | REACHLOCAL INC | $1,656,000 | +9.3% | 925,000 | +0.8% | 0.65% | +20.1% |
SEAS | New | SEAWORLD ENTMT INC | $1,179,000 | – | 56,000 | +100.0% | 0.46% | – |
MDGS | Buy | MEDIGUS LTDsponsored adr | $1,128,000 | -31.0% | 619,816 | +1.6% | 0.44% | -24.0% |
KODK | New | EASTMAN KODAK CO | $846,000 | – | 78,000 | +100.0% | 0.33% | – |
PTX | New | PERNIX THERAPEUTICS HLDGS IN | $611,000 | – | 582,000 | +100.0% | 0.24% | – |
BKS | Exit | BARNES & NOBLE INC | $0 | – | -200,000 | -100.0% | -0.62% | – |
IILG | Exit | INTERVAL LEISURE GROUP INC | $0 | – | -170,000 | -100.0% | -0.95% | – |
TUMI | Exit | TUMI HLDGS INC | $0 | – | -188,000 | -100.0% | -1.12% | – |
ARCO | Exit | ARCOS DORADOS HOLDINGS INC | $0 | – | -1,180,000 | -100.0% | -1.31% | – |
GNCIQ | Exit | GNC HLDGS INC | $0 | – | -122,000 | -100.0% | -1.35% | – |
Exit | SEAWORLD ENTMT INC | $0 | – | -234,000 | -100.0% | -1.64% | – | |
VSTO | Exit | VISTA OUTDOOR INC | $0 | – | -106,000 | -100.0% | -1.68% | – |
EXEL | Exit | EXELIXIS INC | $0 | – | -1,270,000 | -100.0% | -2.56% | – |
THC | Exit | TENET HEALTHCARE CORP | $0 | – | -252,000 | -100.0% | -2.72% | – |
FL | Exit | FOOT LOCKER INC | $0 | – | -124,000 | -100.0% | -2.88% | – |
JCPNQ | Exit | J.C. PENNEY CO INC | $0 | – | -1,360,000 | -100.0% | -3.23% | – |
ENR | Exit | ENERGIZER HLDGS INC NEW | $0 | – | -300,000 | -100.0% | -3.65% | – |
THRX | Exit | THERAVANCE BIOPHARMA INC | $0 | – | -750,000 | -100.0% | -4.39% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2016-05-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
INCYTE CORP | 21 | Q3 2023 | 2.8% |
VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.